Clinical Trials in Baltimore

Showing 8201-8220 of 23,476 trials

Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS

NCT05457010

The purpose of this study is to evaluate the safety and preliminary activity of ARC-T cells and SPRX002 in participants with relapsed or refractory acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS)

Acute Myeloid LeukemiaMyelodysplastic Syndromes

Arcellx, Inc.24 participantsStarted Nov 2022

Duarte, California, United States • Baltimore, Maryland, United States • Boston, Massachusetts, United States +2 more locations

COMPLETED< 1 mile

An Observational Biomarker Study in Multiple Sclerosis (MS) Patients

NCT05663853

All males and females between 18-70 years of age regardless of their race and ethnicity with a confirmed diagnosis of Primary Progressive Multiple Sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS), and Relapse Remitting Multiple Sclerosis (RRMS) are invited to participate in this Observational study being conducted across four sites in the US. Since this is an observational study no medication/drug or treatment will be given to the participants. The investigator will be collecting information about the participant's MS disease, its progression, current medications, radiographic scans, and blood samples. This will help the investigator evaluate the biomarkers and new treatment options to better understand the MS disease process.

Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Secondary Progressive

LAPIX Therapeutics Inc.137 participantsStarted Mar 2023

Baltimore, Maryland, United States • Chevy Chase, Maryland, United States • New York, New York, United States +1 more locations

Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS

An Observational Biomarker Study in Multiple Sclerosis (MS) Patients

Find Trials by Condition in Baltimore

A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat

Trial for Treatment Refractory Trigeminal Neuralgia

Investigating Distress Tolerance in Adults With Tourette Syndrome

A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC)

Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)

Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301)

Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis

Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye

Coronary Microvascular Disease (CMD) Registry

Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants

Trim II for Noninvasive Lipolysis and Circumference Reduction of Abdomen.

Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant

House Dust Mite Allergy Trial In Children

Perampanel Titration and Cognitive Effects

Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease

Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar Formation

A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects